STATE STREET CORP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 52 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$148,285
-25.1%
56,814
+2.7%
0.00%
Q2 2023$197,981
+68.6%
55,302
+2.7%
0.00%
Q1 2023$117,428
-90.4%
53,866
-47.2%
0.00%
Q4 2022$1,226,892
+302.3%
101,986
+117.0%
0.00%
Q3 2022$305,000
+44.5%
46,992
+2.1%
0.00%
Q2 2022$211,000
-95.5%
46,009
-91.4%
0.00%
Q1 2022$4,651,000
-36.4%
537,670
+5.0%
0.00%
Q4 2021$7,315,000
-31.8%
512,246
+5.0%
0.00%
-100.0%
Q3 2021$10,726,000
+127.8%
487,999
+38.7%
0.00%
Q2 2021$4,709,000351,9200.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 781,292$2,039,1721.87%
GSA CAPITAL PARTNERS LLP 88,923$2320.02%
Glass Jacobson Investment Advisors llc 12,255$31,9860.02%
Rathbones Group PLC 289,803$756,3860.01%
N.E.W. Advisory Services LLC 12,960$33,8260.01%
Virtu Financial LLC 17,388$450.00%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$14,6870.00%
ALGERT GLOBAL LLC 14,680$380.00%
Close Asset Management Ltd 11,400$300.00%
Altshuler Shaham Ltd 12,847$33,4080.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders